pharma · Glioblastoma · Unresectable or metastatic soft tissue sarcoma
Philogen
Philogen S.p.A.
Philogen S.p.A is a pharma organization headquartered in SIENA, IT. Primary therapeutic focus areas include Glioblastoma, Unresectable or metastatic soft tissue sarcoma, Cutaneous Squamous Cell Carcinoma, locally advance
Loc. Bellaria, 35, Sovicille, SIENA 53018, IT HQ
1996 Founded
180 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Loc. Bellaria, 35, Sovicille, SIENA 53018, IT
- Founded
- 1996
- Employees
- 180
- Programs
- 18
- Drugs
- 29
- Patents
- 0
PH-FAPLU-02-23
Phase 1 · other · Patients with advanced/metastatic FAP-positive tumors
PH-FAPLU-02-23 for Patients with advanced/metastatic FAP-positive tumors is a Phase 1 program (other) at Philogen S.p.A. with 1 ClinicalTrials.gov record(s).
Internal code PH-FAPLU-02-23
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Philogen S.p.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- Patients with advanced/metastatic FAP-positive tumors
- Status
- active
- Trials
- 1